Anti-Retroviral Therapy Increases the Prevalence of Dyslipidemia in South African HIV-Infected Patients.
about
Defining a research agenda to address the converging epidemics of tuberculosis and diabetes. Part 1: Epidemiology and clinical management.Lipid testing in infectious diseases: possible role in diagnosis and prognosis.High prevalence of "non-dipping" blood pressure and vascular stiffness in HIV-infected South Africans on antiretroviralsDiabetes, metabolic syndrome and dyslipidemia in people living with HIV in Africa: re-emerging challenges not to be forgotten.Atherogenic index of plasma and 10-year risk of cardiovascular disease in adult Africans living with HIV infection: A cross-sectional study from Yaoundé, Cameroon.
P2860
Anti-Retroviral Therapy Increases the Prevalence of Dyslipidemia in South African HIV-Infected Patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Anti-Retroviral Therapy Increa ...... African HIV-Infected Patients.
@ast
Anti-Retroviral Therapy Increa ...... African HIV-Infected Patients.
@en
type
label
Anti-Retroviral Therapy Increa ...... African HIV-Infected Patients.
@ast
Anti-Retroviral Therapy Increa ...... African HIV-Infected Patients.
@en
prefLabel
Anti-Retroviral Therapy Increa ...... African HIV-Infected Patients.
@ast
Anti-Retroviral Therapy Increa ...... African HIV-Infected Patients.
@en
P2093
P2860
P1433
P1476
Anti-Retroviral Therapy Increa ...... African HIV-Infected Patients.
@en
P2093
Joel A Dave
Miguel Lacerda
Naomi S Levitt
P2860
P304
P356
10.1371/JOURNAL.PONE.0151911
P407
P577
2016-03-17T00:00:00Z